Jurox's Alfaxan anaesthetic licensed for use in rabbits

Animal Health Supplier News

Jurox has announced that its successful anaesthetic product Alfaxan has been licensed for use in rabbits for the first time.

Alfaxan contains alfaxalone as its active ingredient and has been shown to provide a wide safety margin and an excellent cardio-respiratory profile, as well as being dosed to effect. Currently, it is available for use in the treatment of dogs and cats.

“Jurox's Alfaxan anaesthetic product has been licensed for the induction of anaesthesia in pet rabbits.“

It has been licensed for the induction of anaesthesia in pet rabbits as it can provide smooth and rapid induction and recovery, painless administration and good muscle relaxation, with low impact on ventilation and blood pressure - important considerations for prey species that are highly vulnerable to stress.

Rabbits are the third most commonly anaesthetised pet in the UK, but have an overall risk of perioperative death that is seven times greater than for dogs.

Richard Beckwith, country manager of Jurox, said: "With Alfaxan, we hope to make a contribution to the future of veterinary anaesthesia in the UK and are confident our clients will be able to deliver the best practice anaesthesia they believe in."

With over 20 years of experience within the animal health market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current animal health roles we have available, you can search for the latest job roles, register your details, or contact the team today.

See all the latest jobs in Animal Health
Return to news